Search clinical trials for: IGIMRT 27 Gy in 3 fractions

Total 38 results

Memorial Sloan Kettering Cancer Center
University of Pisa; University of California, San Francisco; The Champalimaud...

Active, not recruiting

Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy

Melanoma | Sarcoma | Ovarian Cancer | Bone | Soft Tissue | Lymph Nodes | CNS-Spinal CD/MEMBR, NOS

United States, Italy, Portugal
UMC Utrecht

Unknown

Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer

Pancreatic Cancer

Netherlands
Fundacao Champalimaud

Completed

Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer (PROSINT)

PROSTATE CANCER

Portugal
Norwegian University of Science and Technology
Oslo University Hospital; University Hospital of North Norway; Sorlandet Hospital... and other collaborators

Active, not recruiting

Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer (THORA)

Small Cell Lung Carcinoma

Denmark, Sweden, Norway
Virginia Commonwealth University

Terminated

Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's

Alzheimer's Disease

United States
Barretos Cancer Hospital

Terminated

Hypofractionated Radiotherapy for Nonmelanoma Skin Cancer

Non-melanoma Skin Cancer

Brazil
Canadian Cancer Trials Group
Trans Tasman Radiation Oncology Group

Completed

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

Spinal Metastases

Canada, Australia
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule in Locally Advanced Carcinoma of Uterine Cervix

Squamous Cell Carcinoma of Cervix

Bangladesh
Institut Català d'Oncologia

Unknown

Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases (sbrtlungfff)

Carcinoma, Non-Small-Cell Lung | Neoplasm Metastasis

Spain
Institute of Cancer Research, United Kingdom

Unknown

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Prostate Cancer

United Kingdom
Weill Medical College of Cornell University
Viewray Inc.

Active, not recruiting

Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks

Prostate Cancer

United States
Sunnybrook Health Sciences Centre

Recruiting

A Phase II Trial of Intermediate Radiation Dose For Lymphoma

Follicular Lymphoma

Canada
McGill University Health Centre/Research Institute...

Enrolling by invitation

Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT) (StAR-VT)

Arrhythmia | Ventricular Tachycardia | Radiation Toxicity | Arrhythmic Storm

Canada
Lawson Health Research Institute

Terminated

Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial (FLAIR)

Non-small Cell Lung Cancer

Canada
Centre hospitalier de l'Université de Montréal...

Terminated

Phase I-II Study on Treatment of Advanced Oropharynx Cancer in Elderly Population by Intensity Modulated Radiotherapy With Treatment Volume Reduction and Combination Chemotherapy

Head and Neck Cancer

Canada
University of Sydney
National Health and Medical Research Council, Australia; European Organisation... and other collaborators

Active, not recruiting

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer (ENZARAD)

Prostatic Neoplasms

United States, Australia, United Kingdom, Spain, New Zealand, Ireland, Austria, Belgium, Slovenia
Janjira Petsuksiri
Mahidol University

Not yet recruiting

Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

Thyroid Associated Ophthalmopathy

Thailand
Wuhan Union Hospital, China

Unknown

Whole Versus Partial Vertebral Body IMRT for Spinal Metastases

Pain
University of Texas Southwestern Medical Center

Completed

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Institut Claudius Regaud

Recruiting

A Study to Evaluate Pre- or Post-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa. (HYPOSARC)

Soft Tissue Sarcoma

France
Fundacao Champalimaud

Unknown

Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

Adenocarcinoma of the Prostate

Portugal
Royal Marsden NHS Foundation Trust
Merck Sharp & Dohme LLC

Terminated

PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer Patients (PRIMING)

Metastatic Non-small-cell lunG Cancer

United Kingdom
Stanford University

Completed

Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)

Non-small Cell Lung Cancer (NSCLC)

United States, Japan, Canada
King Faisal Specialist Hospital & Research Center
Radiation Therapy Oncology Group

Completed

A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors

Malignant Salivary Gland Tumors

Saudi Arabia
Trans Tasman Radiation Oncology Group

Active, not recruiting

Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPVOropharynx)

HPV Positive Oropharyngeal Squamous Cell Carcinoma

Australia, New Zealand
University Hospital, Bordeaux

Active, not recruiting

Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy (GRECCAR12)

Rectal Cancer

France
Albert Einstein College of Medicine

Active, not recruiting

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer (PROSINT)

Prostate Cancer

United States
State University of New York - Upstate Medical...

Recruiting

Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

Non-small Cell Lung Cancer

United States
AHS Cancer Control Alberta

Recruiting

Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients

Glioblastoma Multiforme

Canada
Olivia Newton-John Cancer Research Institute
Austin Health; Roche Products Pty Limited; Ballarat Health Services

Active, not recruiting

Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy (FLUORO)

Follicular Lymphoma

Australia
University of Michigan Rogel Cancer Center
Rush University Medical Center

Completed

Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

Pancreatic Cancer

United States
Danish Headache Center

Completed

The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache

Migraine

Denmark
Assistance Publique - Hôpitaux de Paris

Withdrawn

Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac Shunt (ReVAch)

Pulmonary Arterial Hypertension With Congenital Cardiac Shunt
Fred Hutchinson Cancer Center

Terminated

O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas

Glioblastoma | Gliosarcoma

United States
Case Comprehensive Cancer Center

Completed

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell... and other conditions

United States
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

Stage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Limited Stage Lung Small Cell Carcinoma | Stage I Lung Cancer AJCC v8

United States, Japan
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 Neuroblastoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

PRETEXT I Hepatoblastoma | PRETEXT II Hepatoblastoma | PRETEXT III Hepatoblastoma | PRETEXT IV Hepatoblastoma

United States, Canada, Puerto Rico, Australia, Japan, Brazil

Search clinical trials for: IGIMRT 27 Gy in 3 fractions

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations